110 related articles for article (PubMed ID: 7705805)
1. Heparan sulfate proteoglycan expression in normal human liver.
Roskams T; Moshage H; De Vos R; Guido D; Yap P; Desmet V
Hepatology; 1995 Apr; 21(4):950-8. PubMed ID: 7705805
[TBL] [Abstract][Full Text] [Related]
2. Distribution and origin of the basement membrane component perlecan in rat liver and primary hepatocyte culture.
Rescan PY; Loréal O; Hassell JR; Yamada Y; Guillouzo A; Clément B
Am J Pathol; 1993 Jan; 142(1):199-208. PubMed ID: 7678718
[TBL] [Abstract][Full Text] [Related]
3. Heparan sulfate proteoglycan expression in chronic cholestatic human liver diseases.
Roskams T; Rosenbaum J; De Vos R; David G; Desmet V
Hepatology; 1996 Sep; 24(3):524-32. PubMed ID: 8781318
[TBL] [Abstract][Full Text] [Related]
4. Heparan sulphate proteoglycan expression in human primary liver tumours.
Roskams T; De Vos R; David G; Van Damme B; Desmet V
J Pathol; 1998 Jul; 185(3):290-7. PubMed ID: 9771483
[TBL] [Abstract][Full Text] [Related]
5. Expression of extracellular matrix proteoglycans perlecan and decorin in carbon-tetrachloride-injured rat liver and in isolated liver cells.
Gallai M; Kovalszky I; Knittel T; Neubauer K; Armbrust T; Ramadori G
Am J Pathol; 1996 May; 148(5):1463-71. PubMed ID: 8623917
[TBL] [Abstract][Full Text] [Related]
6. Expression of the basement membrane heparan sulfate proteoglycan (perlecan) in human synovium and in cultured human synovial cells.
Dodge GR; Boesler EW; Jimenez SA
Lab Invest; 1995 Nov; 73(5):649-57. PubMed ID: 7474938
[TBL] [Abstract][Full Text] [Related]
7. [Morphology of basement membrane and associated matrix proteins in normal and pathological tissues].
Nerlich A
Veroff Pathol; 1995; 145():1-139. PubMed ID: 8638427
[TBL] [Abstract][Full Text] [Related]
8. Altered expression and distribution of heparan sulfate proteoglycans in human gliomas.
Steck PA; Moser RP; Bruner JM; Liang L; Freidman AN; Hwang TL; Yung WK
Cancer Res; 1989 Apr; 49(8):2096-103. PubMed ID: 2522816
[TBL] [Abstract][Full Text] [Related]
9. Perlecan is responsible for thrombospondin 1 binding on the cell surface of cultured porcine endothelial cells.
Vischer P; Feitsma K; Schön P; Völker W
Eur J Cell Biol; 1997 Aug; 73(4):332-43. PubMed ID: 9270876
[TBL] [Abstract][Full Text] [Related]
10. Developmental and cell-type-specific expression of cell surface heparan sulfate proteoglycans in the rat heart.
Asundi VK; Keister BF; Stahl RC; Carey DJ
Exp Cell Res; 1997 Jan; 230(1):145-53. PubMed ID: 9013716
[TBL] [Abstract][Full Text] [Related]
11. Normal labor associated with changes in uterine heparan sulfate proteoglycan expression and localization.
Hjelm Cluff A; Malmström A; Tingåker B; David G; Ekman-Ordeberg G
Acta Obstet Gynecol Scand; 2005 Mar; 84(3):217-24. PubMed ID: 15715528
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical localization of heparan sulfate proteoglycan in rat tibiae.
Nakamura H; Ozawa H
J Bone Miner Res; 1994 Aug; 9(8):1289-99. PubMed ID: 7976511
[TBL] [Abstract][Full Text] [Related]
13. Characterization of proteoglycans synthesized by murine embryonal carcinoma cells (P19) reveals increased expression of perlecan (heparan sulfate proteoglycan) during neuronal differentiation.
Sekiguchi RT; Potter-Perigo S; Braun K; Miller J; Ngo C; Fukuchi K; Wight TN; Kimata K; Snow AD
J Neurosci Res; 1994 Aug; 38(6):670-86. PubMed ID: 7807583
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the expression of agrin, a basement membrane heparan sulfate proteoglycan, in cholangiocarcinoma and hepatocellular carcinoma.
Batmunkh E; Tátrai P; Szabó E; Lódi C; Holczbauer A; Páska C; Kupcsulik P; Kiss A; Schaff Z; Kovalszky I
Hum Pathol; 2007 Oct; 38(10):1508-15. PubMed ID: 17640714
[TBL] [Abstract][Full Text] [Related]
15. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
Tátrai P
Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
[TBL] [Abstract][Full Text] [Related]
16. Expression of perlecan, a proteoglycan that binds myogenic inhibitory basic fibroblast growth factor, is down regulated during skeletal muscle differentiation.
Larraín J; Alvarez J; Hassell JR; Brandan E
Exp Cell Res; 1997 Aug; 234(2):405-12. PubMed ID: 9260911
[TBL] [Abstract][Full Text] [Related]
17. Endocytosis of decorin by bovine aortic endothelial cells. off.
Götte M; Kresse H; Hausser H
Eur J Cell Biol; 1995 Mar; 66(3):226-33. PubMed ID: 7774608
[TBL] [Abstract][Full Text] [Related]
18. Abnormal expression of perlecan proteoglycan in metastatic melanomas.
Cohen IR; Murdoch AD; Naso MF; Marchetti D; Berd D; Iozzo RV
Cancer Res; 1994 Nov; 54(22):5771-4. PubMed ID: 7954396
[TBL] [Abstract][Full Text] [Related]
19. In vitro changes in plasma membrane heparan sulfate proteoglycans and in perlecan expression participate in the regulation of fibroblast growth factor 2 mitogenic activity.
Guillonneau X; Tassin J; Berrou E; Bryckaert M; Courtois Y; Mascarelli F
J Cell Physiol; 1996 Jan; 166(1):170-87. PubMed ID: 8557766
[TBL] [Abstract][Full Text] [Related]
20. Biochemical characterization of heparan sulfate derived from murine hemopoietic stromal cell lines: a bone marrow-derived cell line S17 and a fetal liver-derived cell line AFT024.
Arcanjo K; Belo G; Folco C; Werneck CC; Borojevic R; Silva LC
J Cell Biochem; 2002; 87(2):160-72. PubMed ID: 12244569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
